Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    February 2018
  1. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    PubMed     Text format     Abstract available


    January 2018
  2. LIU G, Sharma M, Tan N, Barnabas R, et al
    HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.
    AIDS. 2018 Jan 24. doi: 10.1097/QAD.0000000000001765.
    PubMed     Text format     Abstract available


    August 2017
  3. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
    AIDS. 2017;31:1859-1866.
    PubMed     Text format     Abstract available


    July 2017
  4. BURGOS J, Hernandez-Losa J, Landolfi S, Guelar A, et al
    The role of oncogenic HPV determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001605.
    PubMed     Text format     Abstract available


  5. VIEIRA VA, Avelino-Silva VI, Cerqueira NB, Costa DA, et al
    Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T cell activation.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001580.
    PubMed     Text format     Abstract available


  6. VAN ZUMMEREN M, Kremer WW, Van Aardt MC, Breytenbach E, et al
    Selection of women at risk for cervical cancer in an HIV-infected SOUTH AFRICAN population.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001583.
    PubMed     Text format     Abstract available


  7. STONER MCD, Pettifor A, Edwards JK, Aiello AE, et al
    The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001584.
    PubMed     Text format     Abstract available


    May 2017
  8. OMORI R, Abu-Raddad LJ
    Sexual network drivers of HIV and herpes simplex virus type 2 (HSV-2) transmission: a comparative mathematical modeling analysis.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001542.
    PubMed     Text format     Abstract available


  9. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in MSM.
    AIDS. 2017;31:1169-1180.
    PubMed     Text format     Abstract available


    March 2017
  10. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    PubMed     Text format     Abstract available


  11. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    PubMed     Text format     Abstract available


  12. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    PubMed     Text format     Abstract available


    February 2017
  13. COMBES JD, Clifford GM, Egger M, Cavassini M, et al
    Human papillomavirus antibody response following HAART initiation among MSM.
    AIDS. 2017;31:561-569.
    PubMed     Text format     Abstract available


    January 2017
  14. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    PubMed     Text format     Abstract available


  15. MAKAROVA N, Henning T, Taylor A, Dinh C, et al
    Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001389.
    PubMed     Text format     Abstract available


    December 2016
  16. SERRANO-VILLAR S, Vasquez-Dominguez E, Perez-Molina JA, Sainz T, et al
    HIV, HPV and microbiota: partners in crime?
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2016
  17. ORANG'O O, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    October 2016
  18. KELLY HA, Sawadogo B, Chikandiwa A, Segondy M, et al
    Epidemiology of High-risk Human Papillomavirus and Cervical Lesions in African women living with HIV/AIDS: Effect of Anti-Retroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    January 2016
  19. KONOPNICKI D, Manigart Y, Gilles C, Barlow P, et al
    High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
    AIDS. 2016;30:425-433.
    PubMed     Text format     Abstract available


  20. PICARD A, Badoual C, Hourseau M, Halimi C, et al
    HPV prevalence in HIV patients with head and neck squamous cell carcinoma.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  21. SENDAGORTA E, Bernardino JI, Alvarez-Gallego M, Feito M, et al
    Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
    AIDS. 2016;30:75-82.
    PubMed     Text format     Abstract available


  22. MOOIJ SH, van Santen DK, Geskus RB, van der Sande MA, et al
    The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.
    AIDS. 2016;30:121-32.
    PubMed     Text format     Abstract available


  23. COGHILL AE, Shiels MS, Rycroft RK, Copeland G, et al
    Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
    AIDS. 2016;30:105-12.
    PubMed     Text format     Abstract available


  24. GESKUS RB, Gonzalez C, Torres M, Del Romero J, et al
    Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    AIDS. 2016;30:37-44.
    PubMed     Text format     Abstract available


  25. PARK LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, et al
    Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.
    AIDS. 2016;30:273-91.
    PubMed     Text format     Abstract available


    November 2015
  26. SIRERA G, Videla S, Verges J, Chamorro A, et al
    Aggressive human papillomavirus (HPV)-11-related sinonasal inverted papilloma in an HIV-infected patient and the quadrivalent HPV vaccine: a case report.
    AIDS. 2015;29:2366-8.
    PubMed     Text format    


    September 2015
  27. KINUTHIA J, Drake AL, Matemo D, Richardson BA, et al
    HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics.
    AIDS. 2015;29:2025-33.
    PubMed     Text format     Abstract available


    July 2015
  28. MCCLELLAND RS, Richardson BA, Cherutich P, Mandaliya K, et al
    Impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers: a 15-year prospective cohort study.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  29. DE MARTEL C, Shiels MS, Franceschi S, Simard EP, et al
    Cancers attributable to infections among adults with HIV in the United States.
    AIDS. 2015.
    PubMed     Text format     Abstract available


    June 2015
  30. MASESE L, Baeten JM, Richardson BA, Bukusi E, et al
    Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.
    AIDS. 2015;29:1077-85.
    PubMed     Text format     Abstract available


    March 2015
  31. RAINONE V, Giacomet V, Penagini F, Fabiano V, et al
    Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults.
    AIDS. 2015;29:739-43.
    PubMed     Text format     Abstract available


  32. BURGOS J, Curran A, Tallada N, Guelar A, et al
    Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM.
    AIDS. 2015;29:695-702.
    PubMed     Text format     Abstract available


    November 2014
  33. ZEIER MD, Botha MH, Engelbrecht S, Machekano RN, et al
    Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV.
    AIDS. 2014.
    PubMed     Text format     Abstract available


    September 2014
  34. MASSAD LS, Xie X, Burk R, Keller MJ, et al
    Long-term cumulative detection of human papillomavirus among HIV seropositive women.
    AIDS. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: